Заранее благодарю!
1. Eur. J. Pharm. Biopharm. 2014, 86, 83-89.
Ong H. X., Benaouda F., Traini D., Cipolla D., Gonda I., Bebawy M., Forbes B., Young P. M.
In vitro and ex vivo methods predict the enhanced lung residence time of liposomal ciprofloxacin formulations for nebulisation.
- DOI:
http://dx.doi.org/10.1016/j.ejpb.2013.06.024
Kupetz E., Preu L., Kunick C., Bunjes H.
Parenteral formulation of an antileishmanial drug candidate – Tackling poor solubility, chemical instability, and polymorphism.
- DOI:
http://dx.doi.org/10.1016/j.ejpb.2013.02.001
Zeng S., Hu C., Wei H., Lu Y., Zhang Y., Yang J., Yun G., Zou W., Song B.
Intravitreal pharmacokinetics of liposome-encapsulated amikacin in a rabbit model.
- DOI:
http://dx.doi.org/10.1016/S0161-6420(93)31423-5
Код: Выделить всё
www.sciencedirect.com/science/article/pii/S0161642093314235Bermudez L. E.
Use of liposome preparation to treat mycobacterial infections.
- DOI:
http://dx.doi.org/10.1016/S0171-2985(11)80465-1